John Mark Sloan (J M Sloan, J Mark Sloan)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 19

Top Topics

Venous Thromboembolism

Multiple Myeloma

Respiratory Syndrome Coronavirus

Stem Cell Transplantation

Top Venues

Bone marrow transplantation

Advances in hematology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Rena Zheng, Alexandra Lauren Solomon, Madeline A DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali A Dhongade, Michael A Garcia, Robert T Eberhardt, John Mark Sloan, Janice Weinberg, Elizabeth S Klings
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients. Advances in hematology 2024 (2024)
Rena Zheng, Alexandra Lauren Solomon, Madeline A DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali A Dhongade, Michael A Garcia, Robert T Eberhardt, John Mark Sloan, Janice Weinberg, Elizabeth S Klings
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients. Advances in hematology 2024 (2024)
Rena Zheng, Alexandra Lauren Solomon, Madeline A DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali A Dhongade, Michael A Garcia, Robert T Eberhardt, John Mark Sloan, Janice Weinberg, Elizabeth S Klings
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients. Advances in hematology 2024 (2024)
Rena Zheng, Alexandra Lauren Solomon, Madeline A DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali A Dhongade, Michael A Garcia, Robert T Eberhardt, John Mark Sloan, Janice Weinberg, Elizabeth S Klings
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients. Advances in hematology 2024 (2024)
Meredith Halpin, Adam Lerner, Manish Sagar, Praveen Govender, Bhavesh Shah, Janice Weinberg, Shayna Sarosiek, John Mark Sloan
A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19. medRxiv : the preprint server for health sciences (2023)
Joshua N Gustine, Andrew Staron, Raphael E Szalat, Lisa M Mendelson, Tracy Joshi, Frederick L Ruberg, Omar Siddiqi, Deepa M Gopal, Camille Vanessa Edwards, Andrea Havasi, Michelle C Kaku, K H Vincent Lau, John L Berk, John Mark Sloan, Vaishali Sanchorawala
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. American journal of hematology 97 (9) (2022)
Ganimete Lamaj, Alberto Pablo-Trinidad, Ian Butterworth, Nolan Bell, Ryan Benasutti, Aurelien Bourquard, Alvaro Sánchez-Ferro, Carlos Castro-Gonzalez, Ana Jiménez-Ubieto, Tycho Baumann, Antonia Rodriguez-Izquierdo, Elizabeth Pottier, Anthony C Shelton, Joaquin Martinez Lopez, John Mark Sloan
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study. Journal of medical Internet research 24 (8) (2022)
Vanessa Fiorini Furtado, Dina Brauneis, Janice Weinberg, Noon Elhassan, John Mark Sloan, Vaishali Sanchorawala
Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis. Bone marrow transplantation (2021)
Robert J Smyth, John Mark Sloan, Eric J Burks, Finn J Hawkins
Primary pulmonary marginal zone lymphoma: an unusual cause of pulmonary infiltrates. Respirology case reports 9 (8) (2021)
Brett Dumas, Hassan Yameen, Shayna R Sarosiek, John Mark Sloan, Vaishali Sanchorawala
Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 27 (4) (2020)
Raphael Szalat, Shayna R Sarosiek, Andrea Havasi, Dina Brauneis, John Mark Sloan, Vaishali Sanchorawala
Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis. Leukemia 35 (3) (2020)
Pooja Phull, Vaishali Sanchorawala, Dina Brauneis, John Mark Sloan, Omar K Siddiqi, Karen Quillen, Shayna R Sarosiek
High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone marrow transplantation 54 (8) (2019)
Andrew Staron, Yachana Kataria, David L Murray, John Mark Sloan, Vaishali Sanchorawala
Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. American journal of hematology 95 (2) (2019)
Paul S White, Pooja Phull, Dina Brauneis, John Mark Sloan, Karen Quillen, Shayna Sarosiek, Vaishali Sanchorawala
High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone marrow transplantation 53 (12) (2018)
Shayna R Sarosiek, Karen Quillen, John Mark Sloan, Dina Brauneis, Vaishali Sanchorawala
Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood 132 (7) (2018)
Sabrina L Browning, Karen Quillen, John Mark Sloan, Gheorghe Doros, Shayna R Sarosiek, Vaishali Sanchorawala
Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood 130 (11) (2017)
V P Nguyen, D Brauneis, M Kaku, John Mark Sloan, S Sarosiek, K Quillen, A C Shelton, Vaishali Sanchorawala
Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone marrow transplantation 53 (3) (2017)
Vaishali Sanchorawala, Anthony C Shelton, Stephen Lo, Cindy Varga, John Mark Sloan, David C Seldin
Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial. Blood 128 (8) (2016)
Vaishali Sanchorawala, Fangui Sun, Karen Quillen, John Mark Sloan, John L Berk, David C Seldin
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood 126 (20) (2015)